BDRX
Biodexa Pharmaceuticals plc American Depositary Shs
Pharmaceutical Preparations
Best Pharmaceutical Stocks 2026 →
BDRX Stock Analysis: Buy, Sell, or Hold?
$2.39
-0.07 (-2.85%)
▼
5d:
-11.15%
30d:
+582.47%
90d:
+53.21%
QUANTITATIVE VERDICT
WAIT
LOW Confidence (37%)
Quality Score
32/100
Position
SLIGHTLY HIGH
30-Day Fair Range
$0.30 – $3.02
Position: SLIGHTLY HIGH
Wall Street Target
$72.40
+2843.3% upside
Options IV & Volume
MODERATE Vol
MODERATE volume confirmation
Support / Resistance
$2.28 / $4.23
Trend: Downtrend
Executive Thesis & Bottom Line
Forward Earnings Fair Value & Price Prediction →
⏸️ WAIT FOR STABILIZATION: BDRX is down 11.2% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
Get Alerted When BDRX Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
In-depth Analysis How we analyze
Valuation Analysis: BDRX is currently trading at $2.39, which is considered slightly high relative to its 30-day fair value range of $0.30 to $3.02.
Technical Outlook: Technically, BDRX is in a downtrend. Immediate support is located at $2.28, while resistance sits at $4.23.
Market Sentiment: BDRX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $72.40 (+2843.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, BDRX is in a downtrend. Immediate support is located at $2.28, while resistance sits at $4.23.
Market Sentiment: BDRX scores 0/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $72.40 (+2843.3%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
SLIGHTLY HIGH
Historical Trading Range
$0.30 -
$3.02
Company Quality Score
32/100
(SELL)
Volume Confirmation
MODERATE
Confidence Score
36.8%
Trading Range & Key Levels
30-Day Trading Range
$0.30 -
$3.02
Current vs Trading Range
SLIGHTLY HIGH
Support Level
$2.28
Resistance Level
$4.23
Current Trend
Downtrend
Technical data as of
Nov 10, 2026
Quantitative Signal Breakdown
- BEARISH: Weak technical setup (0/100)
- BULLISH: Trading 2843.3% below Wall St target ($72.40)
- WARNING: Composite score 32/100 in the bottom quintile — this cohort historically lags the market
Fundamental Context
Wall Street Target
$72.40
(+2843.3%)
Revenue Growth (YoY)
-64.1%
Share BDRX Analysis
Share this live BDRX analysis (with rich preview card) to Reddit, StockTwits, X, or embed the chart on your blog.
bloggers & journalists: you are free to use our charts with attribution.
Last updated: November 11, 2026 9:50 AM ET
Data refreshes hourly during market hours. Next update: 10:50 AM
Data refreshes hourly during market hours. Next update: 10:50 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is BDRX showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
RVMD
Revolution Medicines Inc |
STRONG BUY
25 analysts |
$261 | 52 HOLD |
|
VKTX
Viking Therapeutics Inc |
STRONG BUY
21 analysts |
$95 | 42 HOLD |
|
RCUS
Arcus Biosciences Inc |
STRONG BUY
15 analysts |
$41 | 64 BUY |
|
JANX
Janux Therapeutics Inc |
STRONG BUY
18 analysts |
$32 | 46 HOLD |
|
ACHV
Achieve Life Sciences Inc |
STRONG BUY
12 analysts |
$14 | 56 HOLD |
Explore More Analysis & Live Quant Tools
Part A: Deep-Dive BDRX Research Pages
